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ABSTRACT 
 
Canine degenerative myelopathy (DM) is a progressive neurological disorder that may be considered 
to be a large animal model for specific forms of the fatal human disease, familial amyotrophic lateral 
sclerosis (fALS). DM is associated with a c118G>A mutation of the superoxide dismutase 1 (Sod1) 
gene, and a significant proportion of cases are inherited in an autosomal recessive manner in 
contrast to the largely, but not exclusively, dominant mode of inheritance in fALS. The consensus 
view is that these Sod1/SOD1 mutations result in a toxic gain of function but the mechanisms remain 
unclear. Here we used an in vitro neuroblastoma cell line transfection system to monitor wild-type 
and mutant forms of SOD1 fusion proteins containing either a Cherry or an enhanced green 
fluorescent protein (EGFP) tag. These fusion proteins retained SOD1 enzymatic activity on a native 
gel assay system. We demonstrate that SOD1 aggregate density is significantly higher in DM 
transfectants compared to wild-type. In addition, we show by co-immunoprecipitation and confocal 
microscopy, evidence for a potential interaction between wild-type and mutant forms of SOD1 in co-
transfected cells. While in vitro studies have shown SOD1 heterodimer formation in fALS models, 
this is the first report for DM SOD1. Therefore, despite for the majority of cases there is a difference 
in the mode of inheritance between fALS and DM, a similar interaction between wild-type and 
mutant SOD1 forms can occur. Clarifying the role of SOD1 in DM may also be of benefit to 
understanding the role of SOD1 in fALS. 
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